Long-Acting Injectable naltrexone for the Management of patients with Opioid Dependence
Opioid dependence is a condition with serious clinical ramifications. Treatment has focused on detoxification, agonist therapy with methadone or buprenorphine, or remission maintenance with the opioid antagonist, naltrexone. Treatment with oral naltrexone has been limited by poor treatment adherence...
Saved in:
Main Authors: | Kimberly L. Kjome (Author), F. Gerard Moeller (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-Acting Injectable Naltrexone for the Management of Patients with Opioid Dependence
by: Kimberly L. Kjome, et al.
Published: (2011) -
Naltrexone extended-release injection: an option for the management of opioid abuse
by: Taylor Jr R, et al.
Published: (2011) -
Pharmacological enhancement of naltrexone treatment for opioid dependence: a review
by: Peindl K, et al.
Published: (2011) -
Physiologically based pharmacokinetic modeling of long‐acting extended‐release naltrexone in pregnant women with opioid use disorder
by: Babajide Shenkoya, et al.
Published: (2024) -
Naltrexone Implant for Opioid Use Disorder
by: Amber N. Edinoff, et al.
Published: (2021)